Caroline M Loewy
CIK 1367451 · Chief Financial Officer · last filed 2024-06-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
10
Total Filings
38
Lifetime Open-Market Net
$109.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Director | — | $0.00 | — | $0 | 3 | 2024-06-13 |
| CymaBay Therapeutics, Inc. (CBAY) Delisted | Director | — | $32.48 | — | $0 | 11 | 2024-03-22 |
| CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted | Director | 5,828 | $0.05 | $292 | $0 | 1 | 2024-02-16 |
| PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Director | — | $0.07 | — | $0 | 5 | 2022-05-20 |
| Aptose Biosciences Inc. (APTO) Delisted | Director | — | $1.71 | — | $0 | 6 | 2022-01-20 |
| CERO THERAPEUTICS HOLDINGS, INC. (PBAXU) Delisted | Director | — | $10.37 | — | $0 | 1 | 2021-10-12 |
| ZOGENIX, INC. (ZGNX) Delisted | Director | — | $26.68 | — | $0 | 2 | 2021-05-28 |
| LWACU | Director | — | $10.30 | — | $0 | 1 | 2021-01-14 |
| CORT | Chief Financial Officer | — | $82.91 | — | $0 | 1 | 2008-12-02 |
| PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | CFO | 29,900 | — | — | $109.8K | 5 | 2008-03-06 |
Recent Filings · Page 3 of 4
38 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-05-19 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-13 | Aptose Biosciences Inc. (APTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-13 | Aptose Biosciences Inc. (APTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-03 | Aptose Biosciences Inc. (APTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-13 | PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-03-01 | PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-31 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-03 | Aptose Biosciences Inc. (APTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-26 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-09-26 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.